ClearPoint Neuro Inc (NASDAQ:CLPT)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting 1.13. At the close of trading, the stock’s price was $12.59, to imply an increase of 3.37% or $0.41 in intraday trading. The CLPT share’s 52-week high remains $13.47, putting it -6.99% down since that peak but still an impressive 67.83% since price per share fell to its 52-week low of $4.05. The company has a valuation of $347.48M, with an average of 0.14 million shares in intraday trading volume over the past 10 days and average of 240.73K shares over the past 3 months.
ClearPoint Neuro Inc (NASDAQ:CLPT) trade information
After registering a 3.37% upside in the last session, ClearPoint Neuro Inc (CLPT) has traded red over the past five days. The 5-day price performance for the stock is 5.89%, and 28.08% over 30 days. With these gigs, the year-to-date price performance is 85.42%. Short interest in ClearPoint Neuro Inc (NASDAQ:CLPT) saw shorts transact 0.71 million shares and set a 3.11 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The extremes give us $9 and $15 for target low and target high price respectively. As such, CLPT has been trading -19.14% off suggested target high and 28.51% from its likely low.
ClearPoint Neuro Inc (CLPT) estimates and forecasts
Looking at statistics comparing ClearPoint Neuro Inc share performance against respective industry, we note that the company has outperformed competitors. ClearPoint Neuro Inc (CLPT) shares are 74.62% up over the last 6 months, with its year-to-date growth rate higher than industry average at 27.78% against 12.60%. Revenue is forecast to grow 15.00% this quarter before jumping 10.50% for the next one. The rating firms project that company’s revenue will grow 30.80% compared to the previous financial year.
Revenue forecast for the current quarter as set by 3 analysts is 7.78M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 8.02M.Earnings reports from the last fiscal year show that sales brought in 5.76M and 6.81M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 35.00% before jumping 17.80% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -9.74% for the past 5-year period. While 2024 is set for a 25.37% return in earnings, projections for the next 5 years are at 30.00% annually.
CLPT Dividends
ClearPoint Neuro Inc has its next earnings report out on 2024-Nov-07. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
ClearPoint Neuro Inc (NASDAQ:CLPT)’s Major holders
ClearPoint Neuro Inc insiders hold 7.85% of total outstanding shares, with institutional holders owning 30.30% of the shares at 32.88% float percentage. In total, 30.30% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 1.22 million shares (or 4.779% of shares), all amounting to roughly $6.56 million.
The next major institution holding the largest number of shares is MILLENNIUM MANAGEMENT LLC with 0.47 million shares, or about 1.8289% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.51 million.
